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Abstract
Background: Up to 33% of women develop symptoms of posttraumatic stress disorder (PTSD) after a traumatic
birth experience. Negative and traumatic childbirth experiences can also lead to fear of childbirth, avoiding or
negatively influencing a subsequent pregnancy, mother-infant bonding problems, problems with breastfeeding,
depression and reduced quality of life. For PTSD in general, eye movement desensitization and reprocessing (EMDR)
therapy has proven to be effective. However, little is known about the preventive effects of early intervention EMDR
therapy in women after a traumatic birth experience. The purpose of this study is to determine the effectiveness of
early intervention EMDR therapy in preventing PTSD and reducing PTSD symptoms in women with a traumatic
birth experience.
Methods: The PERCEIVE study is a randomized controlled trial. Women suffering from the consequences of a
traumatic birth experience will be randomly allocated at maximum 14 days postpartum to either EMDR therapy or
‘care-as-usual’. Patients in the EMDR group receive two sessions of therapy between 14 (T0) and 35 days
postpartum. All participants will be assessed at T0 and at 9 weeks postpartum (T1). At T1, all participants will
undergo a CAPS-5 interview about the presence and severity of PTSD symptoms. The primary outcome measure is
the severity of PTSD symptoms, whereas the secondary outcomes pertain to fear of childbirth, mother-infant
bonding, breastfeeding, depression and quality of life. The study will be conducted at a large city hospital and at
multiple midwifery practices in Amsterdam, the Netherlands.
Discussion: It is to be expected that the results of this study will provide more insight about the safety and
effectiveness of early intervention EMDR therapy in the prevention and reduction of PTSD (symptoms) in women
with a traumatic birth experience.
Trial registration: Netherlands Trial Register NL73231.000.20. Registered on 21 August 2020.
Keywords: Eye movement desensitization and reprocessing therapy, EMDR, Posttraumatic stress disorder, PTSD,
Trauma, Childbirth, Delivery, Obstetrics, Postpartum
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Background
According to recent meta-analyses, 3–4% of all women
develop PTSD following childbirth [1, 2] while up to
33% of women experience symptoms of PTSD [3, 4].
Risk factors for a traumatic birth experience are diverse.
Prevalence of traumatic birth experiences has been
found to be higher among women with unexpected in-
terventions during labour and delivery, such as un-
planned caesarean section or vacuum-assisted delivery
[3, 5]. However, medically uncomplicated deliveries may
also be perceived as traumatic [3, 5–8]. A Dutch retro-
spective survey analysing the perception of over 2000
women with a self-reported traumatic birth experience
showed that lack, or loss, of control (54.6%), and fear for
their baby’s health or life (49.9%), followed by high in-
tensity of pain or physical discomfort (47.4%) attributed
significantly to the traumatic aspect of this experience
[9]. Other reported risk factors include a history of psy-
chiatric illness, previous trauma, fear of childbirth (FoC)
and preeclampsia [2, 5].
According to the Dutch Society of Obstetrics and Gy-
naecology (NVOG) guidelines on birth-related PTSD
(symptoms) [10] and the National Institute for Health
and Care Excellence (NICE) treatment guidelines [11], a
traumatic birth experience is defined as ‘the (subjective)
experience and interpretation of a woman with or with-
out satisfying diagnostic criteria of the Diagnostic and
Statistical Manual of Mental Disorder (DSM-) 5 for
PTSD’ [10, 11]. DSM-5 criteria of PTSD include symp-
toms of re-experiencing, avoidance and numbing, nega-
tive cognitions and mood and hyperarousal [12].
Symptoms may resolve naturally, but in some cases may
lead to a chronic mental health condition [13]. To meet
the diagnostic criteria for PTSD, symptoms must last
longer than 1 month and result in significant dysfunc-
tion. However, due to similarity with physiological symp-
toms associated with a major life event, such as
becoming a parent, PTSD (symptoms) are often not well
recognized. Additionally, PTSD can be confused with
postpartum depression because of a diagnostic overlap
in symptoms such as negative cognitions, or co-
occurrence of both disorders [13].
Besides PTSD, exposure to a negative or traumatic
childbirth frequently results in fear of childbirth (FoC),
avoiding a subsequent pregnancy, reduced quality of life
(QoL), problems with breastfeeding and depression [5,
14–17]. A birth-related trauma causing distress during a
subsequent pregnancy has also been found to be related
to both maternal and foetal negative outcomes, such as
avoiding prenatal care, demanding a planned caesarean
section, and preterm birth [18–21]. Furthermore, trau-
matic birth experiences may negatively influence the
mother-infant bonding with studies showing that chil-
dren from parents with PTSD express a more avoidant
attachment style, caused by feelings of rejection and
anger towards the infant [22, 23]. Mother-infant bonding
and early attachment proves essential for the infants’ fu-
ture self-esteem and resilience, emotion regulation and
their ability to form close relationships [24, 25]. Con-
versely, studies have shown that the presence of PTSD
in parents is associated with the development of psycho-
pathology and higher rates of anxiety and behavioural
problems in their offspring [14, 26]. Moreover, it may
impair early cognitive development of the infant [27]. To
this end, it is conceivable that preventing PTSD, or alle-
viating PTSD symptoms, reduces the likelihood of
mother-infant bonding difficulties, thereby exerting a
positive effect on both the mother and a ‘butterfly effect’
on the infant to create a healthier adult in later life [26].
Hence, research that would identify a short-term and
cost-effective postpartum intervention is important.
Regarding the treatment of PTSD in general, meta-
analyses and treatment guidelines recommend eye move-
ment desensitization and reprocessing (EMDR) therapy as
one of the first-line therapies for this mental health condi-
tion [8, 28–30]. Additionally, encouraging results have been
reported with early EMDR interventions after traumatic
events to reduce PTSD-related symptoms [31, 32]. Al-
though the definition of early intervention varies between
guidelines, a timeframe of treatment within 3 months after
the traumatic incident is mostly considered to be early
intervention [32]. However, a recent review on EMDR ther-
apy studies concluded that ‘research is needed to evaluate
prevention of PTSD, with clinician-administered diagnostic
measures (e.g., CAPS-5) administered to treated and non-
treated individuals’ (p. 245) [33]. Recently, a randomized
controlled pilot study was performed among women with a
traumatic birth experience aimed to study the effect of
EMDR therapy on symptoms of PTSD directly postpartum
in comparison with treatment as usual, which consisted of
standard psychological supportive care. The proportion of
asymptomatic participants was significantly higher in the
EMDR therapy group at 6 weeks postpartum (78.9% vs
39.4%, p = 0.020) although this effect was no longer statisti-
cally significant at 12 weeks postpartum (89.5% vs 66.7%, p
= 0.124) [34]. Since this was a pilot study, sample size was
small (n = 37) which could account for the lack of differ-
ences between groups at 12 weeks postpartum. This en-
couraging result calls for replication through a randomized
controlled trial [33]. Finally, it is important to note that data
on the safety of early interventions following recent trauma,




The main purpose of the study is to determine the safety
and effectiveness of ‘early intervention EMDR’ in
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preventing PTSD or reducing symptoms of PTSD at 9
weeks postpartum in women with a traumatic birth ex-
perience, and to compare these results with care as usual
(CAU) in women who experienced their delivery as a
traumatic event. Safety is defined as the absence of all of
the following adverse events: increased suicidal ideation,
serious self-injurious behaviour or crisis contacts for any
of the aforementioned reasons [37]. It is hypothesized
that early intervention EMDR therapy is safe and that
women who receive early intervention EMDR will report
significantly less PTSD (symptoms) 9 weeks after the de-
livery compared to women who receive no treatment.
Furthermore, our secondary objectives are to determine
the effects of early intervention EMDR therapy on FoC,
QoL, mother-infant bonding (MIB), breastfeeding and
depression. It is hypothesized that early intervention
EMDR will significantly reduce FoC, improve QoL and
MIB, increase the success of breastfeeding and prevent
or reduce depressive symptoms as compared to CAU.
Study design
The PERCEIVE study will use a randomized con-
trolled experimental design. A total of 216 women
with traumatic birth experience will be recruited
within 14 days postpartum and randomized to either
the early EMDR intervention or CAU. Women will be
asked to participate by their midwife or by the re-
searchers at the end of the postpartum midwifery care
period, which is 8 to 10 days postpartum. To ensure
sufficient time to read the patient information and
provide written consent, randomization has been set
to take place at 14 days postpartum. Patients in the
early EMDR therapy group will receive two sessions
of EMDR therapy between 14 and 35 days postpar-
tum as it is expected that a time frame of 3 weeks
(21 days) is feasible to ensure adherence of partici-
pants to the protocol. Patients in the CAU group will
receive no EMDR treatment but will receive two tele-
phone calls during the study period. The two groups
will be compared on a number of outcome variables
before (T0 = 2 weeks) and post-treatment (T1 = 9
weeks; see Figs. 1 and 2). The study endpoint (T1) is
at 9 weeks postpartum to establish the possible pres-
ence of PTSD accurately as defined by the DSM-5
criteria for PTSD.
Women will be recruited in a large hospital and sev-
eral community midwifery practices in the Amsterdam
area, the Netherlands. We expect that the study duration
will encompass 2 years from start inclusions to end in-
clusions. The study protocol is approved by The Medical
Research Ethics Committee of the OLVG Hospital and




Women less than 14 days postpartum who report a trau-
matic birth experience will be asked to participate in this
study. Medical deliveries as well as women who had a
delivery supervised by a primary care midwife from
community midwifery practices in Amsterdam will be
included. Furthermore, they must understand the Dutch
language.
Exclusion criteria
Exclusion criteria include age less than 18 years old,
birth trauma related to a previous birth, recent diagnosis
of a psychiatric disorder, recent or current worsening of
symptoms of a previously diagnosed psychiatric disorder
requiring treatment or a recent history of a suicide at-
tempt, that is, less than 3 months prior to the beginning
of the study.
Procedures and interventions
When women agree to participate, they will receive a
home visit from the researchers to ensure women ac-
knowledged the information and to fill out an informed
consent. After screening and providing informed con-
sent, participants will be randomly allocated to either
the EMDR therapy or the CAU group within 14 days
postpartum (see Fig. 1). Randomization will be on a 1:1
basis by block randomization with random block sized
of two, four or six, performed using Castor EDC [38].
After completing the baseline assessments (T0), partici-
pants will be informed in which group they have been
randomized.
The EMDR therapy group
Participants in the EMDR therapy group will receive two
treatment sessions between 14 and 35 days postpartum,
consisting of 60 min each [39]. The EMDR therapy ses-
sions will be conducted in an out-hospital clinic by
trained psychologists who have completed both the basic
and advanced EMDR therapy training course accredited
by the Dutch National EMDR Association (www.emdr.
nl) and have at least 1 year of experience with providing
EMDR therapy. When the participant or therapist is not
able to be physically present because of the COVID-19
epidemic, therapy sessions may, by exception, be con-
ducted digitally. Digital psychological interventions dur-
ing COVID-19 are supported by the American
Psychiatric Association and the British Psychological So-
ciety [40, 41].
The essence of EMDR therapy is that the therapist
aims to reduce the vividness and emotionality of trauma
memories by asking the patient to recall the trauma
memory while simultaneously making eye movements
[42, 43]. The EMDR therapy will be implemented with
Hendrix et al. Trials          (2021) 22:599 Page 3 of 11
the use of rapid deployment of sets of eye movements
offered by fingers or using a light bar [39]. In case of any
adverse events during the study period, the EMDR ther-
apist will report this to the researcher and set up an in-
dividual plan with regard to the wishes and needs of the
participant.
The CAU group
The CAU group will receive care as provided currently
which means no treatment for their traumatic birth ex-
perience. However, participants in this group will receive
two telephone calls between 14 and 35 days postpartum
to monitor the course of symptoms regarding their trau-
matic birth experience. These conversations will be con-
ducted by the researcher. Preferably, no professional
psychological treatment will be given during the study
period as to not bias the results. Therefore, when a partici-
pant is stable but wishes to receive EMDR treatment, she
will be asked to wait for therapy until she has filled in the
last questionnaires and the Clinician-Administered PTSD
Scale of DSM-5 (CAPS-5) interview is conducted at the
end of the study period (T1). When symptoms of PTSD
significantly worsen during the study period, women will
be referred to their general practitioner who can then refer
the patient to a psychologist or psychiatrist when needed.
When professional psychological help regarding the birth
trauma is started within the study period, this will be reg-
istered and reported as a deviation of the protocol.
Assessments
Screening
After giving birth, all maternity women will receive a
flyer with information about the study, regardless of the
type of delivery or the presence of birth complications.
Eight to 10 days postpartum, all women will be asked
the following question: ‘How did you experience the de-
livery of your baby?’ Depending on the place of the de-
livery, this question will be asked either by the
researcher or by their own midwife. Women will be con-
sidered eligible for the study if the answer includes the
word ‘trauma’ or ‘traumatic’, or when the patient indi-
cates to suffer from symptoms appropriate to PTSD.
Safety
Safety of early intervention EMDR will be monitored by
the therapist. The occurrence of all adverse events,
Fig. 1 Flow chart
Hendrix et al. Trials          (2021) 22:599 Page 4 of 11
which is defined as increased suicidal ideation, serious
self-injurious behaviour or contacts with healthcare pro-
viders in case of mental health crisis, will be reported to
the researcher. Safety of participants in the CAU group
will be monitored by the researchers. Based on regular
phone calls, it will be estimated whether additional inter-
ventions regarding their psychological symptoms are in-
dicated. For both groups, the researcher will register the
adverse event and the general practitioner will be in-
formed to take appropriate measures to ensure the safety
of the participants.
Effectiveness
Other outcome variables will be assessed using multiple
questionnaires. After randomization, but prior to the
treatment (T0), both groups will receive the PTSD
checklist for DSM-5 (PCL-5) [44], World Health
Organization Quality of Life Questionnaire-BREF
(WHOQOL-BREF) [45], Postpartum Bonding Question-
naire (PBQ) [46], Wijma Delivery Expectancy/Experi-
ence Questionnaire version B (W-DEQ B) [47], Early
Postpartum Depression Scale (EPDS) [48] and questions
on breastfeeding (see Figs. 1 and 2). While the
Fig. 2 Enrolment and assessments over time
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experiences of the women are leading in this study, the
results of patients’ questionnaire scores will not influ-
ence the inclusion and randomization process. Question-
naires will be sent through Castor with a unique ID
code. If participants do not have access to a computer,
the questionnaires will be provided on paper with a re-
turn envelope.
Nine weeks postpartum (at T1), each participant in
both groups will undergo a CAPS-5 interview [49] and
will receive the same questionnaires as at T0. To estab-
lish whether the time criterion (i.e. criterion F) of the
DSM-5 criteria for PTSD has been met, the CAPS-5
interview will be conducted 4 weeks after the last EMDR
therapy session in the intervention group, which corre-
sponds to 9 weeks postpartum. The CAPS interview will
be conducted by an independent person who is blinded
to the randomization and who has received official train-
ing in assessment of the CAPS as to not bias the results.
The CAPS version regarding symptoms in the last
month will be used.
Instruments
The following measurement instruments will be used:
Posttraumatic Stress Disorder Checklist (PCL-5)
The PCL-5 is a 20-item self-report questionnaire corre-
sponding to the symptoms in the DSM-5 and is rated
from 0 (not at all) to 4 (extremely) [44]. Total symptom
severity scores ranging from 0 to 80 can be obtained by
summing the scores for each of the 20 items. A total
score ≥31 has been found suggestive for a probable
PTSD in the English version [50]. Additionally, symptom
clusters following the different DSM-5 criteria can be
analysed separately [51]. A previous study found strong
internal consistency, test-retest reliability, convergent
validity and discriminant validity of the PCL-5 [52]. The
reported clinically significant change on a DSM–IV ver-
sion of PCL was found to be 10 points [53]. For the
PCL-5, this clinically significant change has not been set
yet.
Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
PTSD diagnosis as well as PTSD symptom severity will
be assessed by using the Dutch version of the CAPS-5
[49, 54]. The CAPS-5 is a structured clinical interview
that enables standardized DSM-5 PTSD diagnosis based
on symptom severity scores. The interview consists of
20 questions regarding PTSD symptom severity (B–E
items) and several questions concerning other DSM-5
criteria. PTSD diagnosis can be made by following the
DSM-5 diagnostic rule, which requires the A criterion
(exposure to (imminent) dead, severe injury or sexual
violence), ≥1 B item (questions 1–5), ≥1 C item (ques-
tions 6–7), ≥2 D items (questions 8–14), ≥2 E items
(questions 15–20), the F criterion (duration ≥1 month),
G criterion (causing significant suffering or disability)
and H criterion (symptoms are not caused by another
medical condition or substance use). Questions regard-
ing the B-E criteria are rated from 0 (‘absent’) to 4 (‘dis-
abling’). Symptoms rated ≥2 are included in the
calculation for the diagnosis. To assess whether criterion
A was met during birth, specific questions will be used
according to the work of Alcorn et al. [55]. The exact
questions are as follows: (1) ‘Did you feel that your life
or your baby’s life was threatened during or after birth?’
(2) ‘Did you think that you or your baby might die?’ (3)
‘Did you experience an actual injury or threat of serious
injury around the time of birth?’ (4) ‘Did your baby ex-
perience an actual injury or threat of serious injury
around the time or birth?’ [55]. High validity and reli-
ability of the CAPS-5 have been found [49, 56].
World Health Organization Quality of Life assessment
(WHOQOL-BREF) [45]
Quality of life is measured by using the Dutch version of
the WHOQOL-BREF. It contains 26 items covering four
domains: physical health, psychological health, social re-
lationships and environment. Domain scores can be
transformed to a score ranging from 0 to 100 with
higher scores reflecting better quality of life. There is no
cut-off point to demonstrate better or worse quality of
life in this particular population. It has been validated
for this specific population [57].
Postpartum Bonding Questionnaire (PBQ)
Mother to infant bonding is assessed by using the PBQ
[46]. It consists of 25 statements, each followed by a 6-
point Likert scale ranging from ‘Always’ (0) to ‘Never’
(5) with a range of 0–125 with higher scores reflecting a
problematic mother-to-infant bond. Good validity and
reliability of the Dutch version of the PBQ have been
found [58]. To analyse the effects of PTSD symptom se-
verity on the PBQ, only the total score will be used since
later validation studies have not been able to replicate its
factor structure. A score of 26 or higher is suggesting for
some kind of bonding disorder, whereas a score of 40 or
higher indicates severe bonding disorders [59].
Wijma Delivery Experience Questionnaire version B (W-DEQ
B)
The W-DEQ B is used to measure postpartum fear of
childbirth. The W-DEQ is a 33-item self-report ques-
tionnaire assessing FoC during pregnancy (version A),
and after delivery (version B) in terms of the woman’s
cognitive appraisal of childbirth [47]. It was designed
as a monofactorial scale, all 33 items being scored on
a 6-point scale leading to a sum score between 0 and
165, with a higher score equalling more FoC. High
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reliability and promising validity of the W-DEQ B
have been found [47].
Edinburgh Postnatal Depression Scale (EPDS)
The Dutch version of the EPDS is a self-reporting ques-
tionnaire designed to assess pregnancy and postpartum
depression; it is composed of 10 items scored on a 4-
point Likert scale. Higher scores reflect a greater level of
depression severity with a cut-off score of ≥13 to screen
positive for depression [60]. The Dutch version of EPDS
is a widely used measure with good psychometric char-
acteristics [48].
Breastfeeding
Women will be asked whether they had the intention to
breastfeed and whether they are breastfeeding at T0 and
T1 by using ‘yes’ and ‘no’ questions.
Demographics
Questions on the socio-demographic background will be
included consisting of questions on country of birth,
educational level, partner status, previous or current psy-
chologic/psychiatric treatment, previous and or current
medical treatment, medication use, fertility treatment,
planned pregnancy, care in pregnancy, complications
during pregnancy, following a pregnancy course and
preference for mode of delivery (vaginal birth or caesar-
ean section) prior to the actual mode of delivery. Fur-
thermore, medical data on the delivery itself and
demographics will be extracted from the electronic pa-
tient file or the birth report as made by the community
midwife.
Sample size calculation
Based on a mean difference between two treatment arms
of at least 10 points on the PCL-5 scale and a standard
deviation of 20, 86 patients are needed for this study to
be included in each arm. Considering up to 20% loss to
follow-up, 108 patients need to be included per treat-
ment arm. We consider this sample size calculation to
be conservative; the mean and difference estimates used
were based on previous studies with PCL-5 score as the
primary endpoint [61, 62]. The calculation was per-
formed in PASS v11 [63] using an alpha of 0.05 and a
power of 90.3%.
Data management
Privacy of participants will be guaranteed by assigning a
different number to each participant starting with 1 for
the first patient who is included in the study. All gath-
ered data from the participants will be stored under this
number. The data being gathered consists of paper ques-
tionnaires and digital data. The key between the partici-
pant’s code and the data will be stored by the
researchers in an online file which is secured with a
password in a secured digital database. The data from
the questionnaires are gathered using a secured,
encrypted connection (https) and are stored in an online,
password-protected, secured database that is only ac-
cessible by the researchers via Castor EDC. Data will be
exported into separate SPSS to be used for statistical
analyses.
Interview data on paper will be stored in a locked
closet, in a locked room under the participant number,
and only the researchers have access to the key. At the
end of the study, data will be inserted in the same SPSS
file as the electronic data for analyses.
Data will be kept for 20 years in accordance with na-
tional guidelines. We will submit modifications to this
protocol to the approving ethical committee, the institu-
tional review board, participants and investigators.
Due to the minimal risks of the early intervention
EMDR and the short time span of the intervention, a
data monitoring committee is deemed unnecessary.
Statistical analysis
Primary study parameters
For the CAPS-5, an independent t-test will be performed
to compare symptom severity scores between groups at
T1. If the assumption of normality is violated, a Mann-
Whitney U test will be performed. A linear mixed model
analysis will determine the difference between the inter-
vention group and the CAU group in changes in PTSD
symptom severity as measured by the PCL-5 measured
at inclusion and at follow-up (T0 and T1). Changes in
scores of the PCL-5 will be modelled as a function of
the intervention group (EMDR therapy, standard), time
of measurement (T0–screening, T1 follow-up), and the
interaction between time and intervention. Previous and
current psychological treatment, educational level, par-
ity, mode of delivery (vaginal birth, caesarean section,
vacuum-assisted birth) and place of birth (at home, in
the hospital under medical care, in the hospital under
care or the midwife) will be entered as covariates. Per
protocol analyses and intention-to-treat analyses will test
the main effect of treatment condition, the main effect
of time and the interaction effect. The assumptions of
normality, homogeneity of variances and sphericity will
be tested prior to interpreting the results. Furthermore,
adverse events will be reported, and chi-square tests will
be done to test differences in the prevalence of adverse
events between the intervention and the control group.
Secondary study parameters
An independent sample t-test will be used to assess the
differences in scores on the PBQ, W-DEQ B, WHOL-
QOL and EPDS between groups on a continuous scale.
Also, a chi-square test will be conducted to compare the
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frequencies of moderate (scores 26–40) and severe
bonding disorders (scores 40 or higher) on the PBQ, the
presence of FoC by using a cut-off score on the W-DEQ
B of 85 or higher to indicate FoC and the differences in
the prevalence of breastfeeding between groups. Linear
mixed model analyses will determine the difference be-
tween the intervention group and CAU group in scores
on PBQ, W-DEQ B, WHOQOL-BREF and EPDS at in-
clusion and at follow-up (T0 and T1). Previous psycho-
logical treatment, educational level, parity, mode of
delivery and place of birth will be entered as covariates.
Other study parameters
Descriptive statistics will be used to evaluate demo-
graphic and clinical baseline characteristics of the arms
of the trial. Chi-square tests and t-tests will be used to
compare demographic and clinical characteristics of sub-
jects who did not complete the intervention or follow-up
with those of the completers.
Interrater reliability and treatment fidelity
Patients, therapists and researchers will not be blinded
due to the nature of the study. Assessment of the CAPS-
5 interview will be conducted by an independent trained
clinical interviewer, who is not aware of the
randomization result. The therapists are independent of
the research team and work at different sites outside the
hospital. Patients in the EMDR therapy group will be
randomly and equally distributed among therapists. All
EMDR sessions will be recorded on video and randomly
rated for treatment fidelity. During the entire study, dur-
ation group supervision every 2 to 3 months is obliga-
tory for all therapists. After each first session with a new
patient, a case conceptualization will be sent for supervi-
sion including the story of the traumatic event, with a
hierarchy of the most relevant traumatic moments (tar-
gets) regarding the current impairment. Deviations from
the protocol will be noted and reported. If known, thera-
pists register when a patient terminates the study and
the reason for stopping. Furthermore, they inform the PI
about it as soon as possible. Women who withdraw from
treatment will be invited to fill in the previously men-
tioned questionnaires and the CAPS interview.
Dissemination and implementation
After completion of the study, the results will be submit-
ted for publication to peer-reviewed scientific journals.
Furthermore, results will be shared at national and inter-
national conferences, in Dutch or international publica-
tions, and possibly used for education and training
purposes.
Discussion
The PERCEIVE study will be the first randomized con-
trolled trial that examines the safety and effectiveness of
early EMDR therapy in preventing or reducing PTSD
(symptoms) in women with a traumatic birth experience.
We consider this of great importance given the major
impact of PTSD (symptoms) on both mother and infant
found in the literature [14–17]. The processing of having
experienced an impactful event in relation to the birth
of a child is expected to positively influence the women’s
and infants’ quality of life in the longer term.
The study has several strengths. Firstly, the random-
ized controlled design eliminates bias in treatment as-
signment. All women who report having experienced
giving birth as traumatic, despite the type of delivery or
presence of complications and PTSD symptom severity
at baseline, will be included and randomized. Hereby,
the preventive effect of early intervention EMDR, as will
be assessed in this study, may be generalized in all
women reporting a traumatic birth experience. Another
strength of this study is that PTSD (symptoms) will be
assessed using a clinical interview, which will be con-
ducted by an independent assessor 4 weeks after the last
EMDR therapy session to reliably determine the pres-
ence of PTSD. To this end, it is important to note that
this is the first protocol using the CAPS-5 interview in
this specific population, which will add importance to
the study, particularly when compared to past research
which mainly used self-reporting questionnaires. Clearly,
we need to test whether our assumptions are supported,
but we consider it as an advantage that our treatment
protocol consists of only two treatment sessions which
make it easy to implement in existing care systems. An-
other advantage is that the study uses a broad variety of
secondary outcome measures including fear of child-
birth, mother-infant bonding, quality of life, breastfeed-
ing and depression.
Yet, some limitations of the present study should also
be noted. First, due to the nature of the study, patients
and researchers cannot be blinded. To limit potential
bias, women will be informed in which group they are
allocated after finishing the first pre-treatment assess-
ments, and the clinical interview will be conducted by an
independent person. Secondly, since there is no current
protocol for women experiencing traumatic childbirth,
‘usual care’ might differ individually. Therefore, a com-
promise has been made to give all women in the CAU
group an expectative policy. They will receive two tele-
phone calls during the study to monitor their symptom
severity. When symptoms worsen significantly during
the study period, the women in the CAU group will be
referred to their general practitioner. Another limitation
of the study protocol is the definition of the A criterion
in the DSM-V for PTSD diagnosis. Not all women
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reporting a traumatic birth experience will be exposed
to (imminent) dead, severe injury or sexual violence dur-
ing the delivery, which may cause difference in PTSD
diagnoses based on the course of the delivery rather than
the effect of early intervention EMDR therapy itself. To
limit this bias, specific questions focused on childbirth-
related PTSD are added to the A criterion. Finally, be-
cause of the COVID-19 epidemic, patients as well as
therapist will be at risk of being quarantined during the
study period. Given the short time span in which ther-
apy sessions have to be conducted, it is decided to ex-
ceptionally allow therapy sessions to take place digitally
in these cases. Although little is known about the effect-
iveness of online EMDR therapy for PTSD yet, it is ex-
pected that effects may be similar to real-life EMDR
therapy [64].
If early EMDR therapy proves to be effective in pre-
venting or reducing PTSD (symptoms) after a traumatic
birth experience, this would provide a strong argument
for standard screening of women for traumatic experi-
ences after giving birth and to refer them for treatment
in an early phase after the delivery.
Trial status
Protocol version 5, date of approval 10th of February
2021. Screening and recruitment started on 11 Septem-
ber 2020 and will continue to approximately the end of
2022.
Abbreviations
CAPS-5: Clinician-Administered PTSD Scale for DSM-5; CAU: Care as usual;
DSM: Diagnostic and Statistical Manual of Mental Disorders; EMDR: Eye
movement desensitization and reprocessing; EPDS: Edinburgh Postnatal
Depression Scale; FOC: Fear of childbirth; MIB: Mother-infant bonding;
PBQ: Postpartum Bonding Questionnaire; PCL-5: The PTSD Checklist for DSM-
5; PTSD: Posttraumatic stress disorder; QOL: Quality of life; TBE: Traumatic
birth experience; W-DEQ B: Wijma Delivery Experience Questionnaire version
B; WHOQOL-BREF: World Health Organization Quality of Life assessment
Authors’ contributions
All authors have made substantial contributions to the concept of this study.
KD and YH drafted the paper under the supervision of MP. All authors were
involved in critically revising the manuscript and accept the final manuscript.
Funding
The PERCEIVE study is supported by grants from Stichting Wetenschap
OLVG, awarded to the principal investigator MG van Pampus.
Availability of data and materials
Not applicable.
Declarations
Ethics approval and consent to participate
The study was approved by The Medical Research Ethics Committee of the
OLVG Hospital and is registered as NL7323100020. Written, informed consent




The authors declare that they have no competing interests.
Author details
1Department of Obstetrics and Gynaecology, OLVG, Amsterdam, the
Netherlands. 2Academic Centre for Dentistry Amsterdam (ACTA), University
of Amsterdam and VU Amsterdam, Amsterdam, the Netherlands. 3Research
Department, PSYTREC, Bilthoven, the Netherlands. 4School of Health
Sciences, Salford University, Manchester, UK. 5Institute of Health and Society,
University of Worcester, Worcester, UK. 6School of Psychology, Queen’s
University, Belfast, Northern Ireland.
Received: 1 January 2021 Accepted: 16 August 2021
References
1. Yildiz PD, Ayers S, Phillips L. The prevalence of posttraumatic stress disorder
in pregnancy and after birth: a systematic review and meta-analysis. J Affect
Disord. 2017;208:634–45. https://doi.org/10.1016/j.jad.2016.10.009.
2. Grekin R, O'Hara MW. Prevalence and risk factors of postpartum
posttraumatic stress disorder: a meta-analysis. Clin Psychol Rev. 2014;34(5):
389–401. https://doi.org/10.1016/j.cpr.2014.05.003.
3. Creedy DK, Shochet IM, Horsfall J. Childbirth and the development of acute
trauma symptoms: incidence and contributing factors. Birth (Berkeley, Calif).
2000;27(2):104–11.
4. Zaers S, Waschke M, Ehlert U. Depressive symptoms and symptoms of post-
traumatic stress disorder in women after childbirth. J Psychosom Obstet
Gynaecol. 2008;29(1):61–71. https://doi.org/10.1080/01674820701804324.
5. Ayers S, Bond R, Bertullies S, Wijma K. The aetiology of post-traumatic stress
following childbirth: a meta-analysis and theoretical framework. Psychol
Med. 2016;46(6):1121–34. https://doi.org/10.1017/S0033291715002706.
6. Soet JE, Brack GA, DiIorio C. Prevalence and predictors of women’s
experience of psychological trauma during childbirth. Birth (Berkeley, Calif).
2003;30(1):36–46.
7. Stramrood CA, Paarlberg KM, Huis In’t Veld EM, Berger LW, Vingerhoets AJ,
Schultz WC, et al. Posttraumatic stress following childbirth in homelike- and
hospital settings. J Psychosom Obstet Gynaecol. 2011;32(2):88–97. https://
doi.org/10.3109/0167482X.2011.569801.
8. Rijnders M, Baston H, Schönbeck Y, van der Pal K, Prins M, Green J, et al.
Perinatal factors related to negative or positive recall of birth experience in
women 3 years postpartum in the Netherlands. Birth (Berkeley, Calif). 2008;
35(2):107–16.
9. Hollander MH, van Hastenberg E, van Dillen J, van Pampus MG, de Miranda
E, Stramrood CAI. Preventing traumatic childbirth experiences: 2192
women’s perceptions and views. Arch Womens Ment Health. 2017;20(4):
515–23. https://doi.org/10.1007/s00737-017-0729-6.
10. Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG).
Richtlijn Bevallingsgerelateerde PTSS en PTSS klachten: NVOG; 2019.
Available from: https://www.nvog.nl/kwaliteitsdocumenten/richtlijnen/
psychosomatiek
11. National Institute for Health and Care Excellence (NICE). Antenatal and
postnatal mental health: clinical management and service guidance
(CG192). 2014. Available from: https://www.nice.org.uk/guidance/cg192.
12. American Psychiatric Association. Trauma- and stressor-related disorders. In:
Diagnostic and statistical manual of mental disorders. 5th ed. Washington,
DC: American Psychiatric Association; 2013. https://doi.org/10.1176/appi.
books.9780890425596.dsm07.
13. Söderquist J, Wijma B, Wijma K. The longitudinal course of post-traumatic
stress after childbirth. J Psychosom Obstet Gynaecol. 2006;27(2):113–9.
https://doi.org/10.1080/01674820600712172.
14. Davies J, Slade P, Wright I, Stewart P. Posttraumatic stress symptoms
following childbirth and mothers’ perceptions of their infants. Infant Ment
Health J. 2008;29(6):537–54. https://doi.org/10.1002/imhj.20197.
15. Fenech G, Thomson G. Tormented by ghosts from their past’: a meta-
synthesis to explore the psychosocial implications of a traumatic birth on
maternal well-being. Midwifery. 2014;30(2):185–93. https://doi.org/10.1016/j.
midw.2013.12.004.
16. Ghosn F, Almansa B, Moreno-Giménez A, Sahuquillo-Leal R, Serrano-Lozano
E, Hervás D, et al. Trajectories of stress biomarkers and anxious-depressive
symptoms from pregnancy to postpartum period in women with a trauma
Hendrix et al. Trials          (2021) 22:599 Page 9 of 11
history. Eur J Psychotraumatol. 2019;10(1):1601990. https://doi.org/10.1080/2
0008198.2019.1601990.
17. Garthus-Niegel S, Horsch A, Ayers S, Junge-Hoffmeister J, Weidner K,
Eberhard-Gran M. The influence of postpartum PTSD on breastfeeding: a
longitudinal population-based study. Birth (Berkeley, Calif). 2018;45(2):193–
201.
18. Alder J, Fink N, Bitzer J, Hösli I, Holzgreve W. Depression and anxiety during
pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical
review of the literature. J Matern Fetal Neonatal Med. 2007;20(3):189–209.
19. Seng JS, Low LK, Sperlich M, Ronis DL, Liberzon I. Post-traumatic stress
disorder, child abuse history, birthweight and gestational age: a prospective
cohort study. BJOG. 2011;118(11):1329–39.
20. Seng JS, Oakley DJ, Sampselle CM, Killion C, Graham-Bermann S, Liberzon I.
Posttraumatic stress disorder and pregnancy complications. Obstet Gynecol.
2001;97(1):17–22. https://doi.org/10.1016/s0029-7844(00)01097-8.
21. Shaw JG, Asch SM, Kimerling R, Frayne SM, Shaw KA, Phibbs CS.
Posttraumatic stress disorder and risk of spontaneous preterm birth. Obstet
Gynecol. 2014;124(6):1111–9. https://doi.org/10.1097/AOG.
0000000000000542.
22. Bell AF, Andersson E, Goding K, Vonderheid SC. The birth experience and
maternal caregiving attitudes and behavior: a systematic review. Sex Reprod
Healthc. 2018;16:67–77.
23. Hairston I, Handelzalts J, Assis C, Kovo M. Postpartum bonding difficulties
and adult attachment styles: the mediating role of postpartum depression
and childbirth-related PTSD. Infant Ment Health J. 2018;39(2):198–208.
https://doi.org/10.1002/imhj.21695.
24. Rees C. Childhood attachment. Br J Gen Pract. 2007;57(544):920–2.
25. Winston R, Chicot R. The importance of early bonding on the long-term
mental health and resilience of children. London J Prim Care. 2016;8(1):12–
4. https://doi.org/10.1080/17571472.2015.1133012.
26. Rholes WS, Simpson JA, Campbell L, Grich J. Adult attachment and the
transition to parenthood. J Pers Soc Psychol. 2001;81(3):421–35. https://doi.
org/10.1037/0022-3514.81.3.421.
27. Parfitt Y, Pike A, Ayers S. Infant developmental outcomes: a family systems
perspective. Infant Child Dev. 2014;23(4):353–73. https://doi.org/10.1002/
icd.1830.
28. Chen YR, Hung KW, Tsai JC, Chu H, Chung MH, Chen SR, et al. Efficacy of
eye-movement desensitization and reprocessing for patients with
posttraumatic-stress disorder: a meta-analysis of randomized controlled
trials. PLoS One. 2014;9(8):e103676. https://doi.org/10.1371/journal.pone.01
03676.
29. National Institute for Health and Care Excellence (NICE). Post-traumatic
stress disorder (NG116) 2018. Available from: https://www.nice.org.uk/guida
nce/ng116.
30. Bisson JI, Berliner L, Cloitre M, Forbes D, Jensen TK, Lewis C, et al. The
International Society for Traumatic Stress Studies new guidelines for the
prevention and treatment of posttraumatic stress disorder: methodology
and development process. J Trauma Stress. 2019;32(4):475–83. https://doi.
org/10.1002/jts.22421.
31. De Jong A. Presentation: early EMDR intervention. Brussels: EMDR Europe
Association Conference; 2005.
32. Shapiro E, Maxfield L. The efficacy of EMDR early interventions. J EMDR
Pract Res. 2019;13(4):291–301. https://doi.org/10.1891/1933-3196.13.4.291.
33. Matthijssen S, Lee C, Roos C, Barron I, Jarero IN, Shapiro E, et al. The
current status of EMDR therapy, specific target areas, and goals for the
future. J EMDR Pract Res. 2020;14(4):241–84. https://doi.org/10.1891/
EMDR-D-20-00039.
34. Chiorino V, Cattaneo MC, Macchi EA, Salerno R, Roveraro S, Bertolucci GG,
et al. The EMDR Recent Birth Trauma Protocol: a pilot randomised clinical
trial after traumatic childbirth. Psychol Health. 2020;35(7):795–810. https://
doi.org/10.1080/08870446.2019.1699088.
35. Roberts NP, Kitchiner NJ, Kenardy J, Lewis CE, Bisson JI. Early psychological
intervention following recent trauma: a systematic review and meta-
analysis. Eur J Psychotraumatol. 2019;10(1):1695486. https://doi.org/10.1
080/20008198.2019.1695486.
36. Lapp LK, Agbokou C, Peretti CS, Ferreri F. Management of post traumatic
stress disorder after childbirth: a review. J Psychosom Obstet Gynaecol.
2010;31(3):113–22. https://doi.org/10.3109/0167482X.2010.503330.
37. Food and Drug Administration (FDA). What is a serious adverse event?
2016. Available from: http://www.fda.gov/safety/reporting-serious-problems-
fda/what-serious-adverse-event.
38. Castor EDC. Castor electronic data capture. 2019 [27 Aug. 2019]. Available
from: https://castoredc.com.
39. De Jongh A, Ten Broeke E. Handboek EMDR: Een geprotocolleerde
behandelmethode voor de gevolgen van psychotrauma [Handbook EMDR:
a protocol-based treatment method for the consequences of
psychotrauma]. Amsterdam: Pearson Assessment and Information; 2019. p.
222.
40. American Psychiatric Association. Update on telehealth restrictions in




41. British Psychological Society. Adaptations to psychological practice: Interim
guidance during Covid-19 pandemic. Leicester; 2021. Available from: https://
www.bps.org.uk/coronavirus-resources/professional/adaptations-
psychological-practice
42. Shapiro F. Eye movement desensitization and reprocessing (EMDR) therapy:
basic principles, protocols, and procedures. 3rd ed. New York: Guilford
Publications; 2017.
43. De Jongh A, Ten Broeke E, Farrell D, Maxfield L. Empirically supported
psychological treatments: EMDR. In: Handbook of traumatic stress disorders
second edition. Oxford: Oxford University Press; 2020.
44. Boeschoten MA, Bakker A, Jongedijk RA, Olff M. PTSD Checklist for DSM-5–
Dutch Version. Stichting Centrum ’45,Arq Psychotrauma Expert Groep,
Diemen; 2014.
45. World Health Organization (WHO). Development of the World Health
Organization WHOQOL-BREF quality of life assessment. The WHOQOL
Group. Psychol Med. 1998;28(3):551–8.
46. Brockington IF, Oates J, George S, Turner D, Vostanis P, Sullivan M, et al. A
screening questionnaire for mother-infant bonding disorders. Arch Womens
Ment Health. 2001;3(4):133–40. https://doi.org/10.1007/s007370170010.
47. Wijma K, Wijma B, Zar M. Psychometric aspects of the W-DEQ; a new
questionnaire for the measurement of fear of childbirth. J Psychosom Obstet
Gynaecol. 1998;19(2):84–97. https://doi.org/10.3109/01674829809048501.
48. Pop VJ, Komproe IH, van Son MJ. Characteristics of the Edinburgh Post
Natal Depression Scale in The Netherlands. J Affect Disord. 1992;26(2):105–
10. https://doi.org/10.1016/0165-0327(92)90041-4.
49. Boeschoten MA, Van der Aa N, Bakker A, Ter Heide FJJ, Hoofwijk MC,
Jongedijk RA, et al. Development and evaluation of the Dutch Clinician-
Administered PTSD Scale for DSM-5 (CAPS-5). Eur J Psychotraumatol. 2018;
9(1):1546085. https://doi.org/10.1080/20008198.2018.1546085.
50. Ashbaugh AR, Houle-Johnson S, Herbert C, El-Hage W, Brunet A.
Psychometric validation of the English and French versions of the
Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5). PLoS One. 2016;
11(10):e0161645. https://doi.org/10.1371/journal.pone.0161645.
51. Weathers FW, Litz, B.T., Keane, T.M., Palmieri, P.A., Marx, B.P., & Schnurr, P.P.
The PTSD Checklist for DSM-5 (PCL-5): Scale available from the National
Center for PTSD at www.ptsd.va.gov. 2013.
52. Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic
Stress Disorder Checklist for DSM-5 (PCL-5): development and initial
psychometric evaluation. J Trauma Stress. 2015;28(6):489–98. https://doi.
org/10.1002/jts.22059.
53. Monson CM, Gradus JL, Young-Xu Y, Schnurr PP, Price JL, Schumm JA.
Change in posttraumatic stress disorder symptoms: do clinicians and
patients agree? Psychol Assess. 2008;20(2):131–8. https://doi.org/10.1037/104
0-3590.20.2.131.
54. Weathers FW, Blake, D. D., Schnurr, P. P., Kaloupek, D. G., Marx, B. P., & Keane,
T. M. The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) – past
month [measurement instrument]. Available from https://www.ptsd.va.gov.
2015.
55. Alcorn KL, O'Donovan A, Patrick JC, Creedy D, Devilly GJ. A prospective
longitudinal study of the prevalence of post-traumatic stress disorder
resulting from childbirth events. Psychol Med. 2010;40(11):1849–59. https://
doi.org/10.1017/S0033291709992224.
56. Weathers FW, Bovin MJ, Lee DJ, Sloan DM, Schnurr PP, Kaloupek DG, et al.
The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): development
and initial psychometric evaluation in military veterans. Psychol Assess.
2018;30(3):383–95. https://doi.org/10.1037/pas0000486.
57. Webster J, Nicholas C, Velacott C, Cridland N, Fawcett L. Validation of the
WHOQOL-BREF among women following childbirth. Aust N Z J Obstet
Gynaecol. 2010;50(2):132–7. https://doi.org/10.1111/j.1479-828X.2009.01131.x.
Hendrix et al. Trials          (2021) 22:599 Page 10 of 11
58. van Bussel JC, Spitz B, Demyttenaere K. Three self-report questionnaires of
the early mother-to-infant bond: reliability and validity of the Dutch version
of the MPAS, PBQ and MIBS. Arch Womens Ment Health. 2010;13(5):373–84.
https://doi.org/10.1007/s00737-009-0140-z.
59. Brockington IF, Fraser C, Wilson D. The Postpartum Bonding Questionnaire:
a validation. Arch Womens Ment Health. 2006;9(5):233–42. https://doi.org/1
0.1007/s00737-006-0132-1.
60. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression.
Development of the 10-item Edinburgh Postnatal Depression Scale. Br J
Psychiatry. 1987;150:782–6.
61. Zepeda Méndez M, Nijdam MJ, Ter Heide FJJ, van der Aa N, Olff M. A five-
day inpatient EMDR treatment programme for PTSD: pilot study. Eur J
Psychotraumatol. 2018;9(1):1425575. https://doi.org/10.1080/20008198.201
8.1425575.
62. Baas MA, Stramrood CA, Dijksman LM, de Jongh A, van Pampus MG. The
OptiMUM-study: EMDR therapy in pregnant women with posttraumatic
stress disorder after previous childbirth and pregnant women with fear of
childbirth: design of a multicentre randomized controlled trial. Eur J
Psychotraumatol. 2017;8(1):1293315. https://doi.org/10.1080/20008198.201
7.1293315.
63. Hintze J. PASS 11. Kaysville: NCSS, LLC.; 2011.
64. Lenferink LIM, Meyerbröker K, Boelen PA. PTSD treatment in times of
COVID-19: a systematic review of the effects of online EMDR. Psychiatry Res.
2020;293:113438. https://doi.org/10.1016/j.psychres.2020.113438.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Hendrix et al. Trials          (2021) 22:599 Page 11 of 11
